Quantitative and qualitative analysis of integrin subtype expression in melanocytes and melanoma cells

References

• National Cancer Institute, Board PATE. PDQ Melanoma Treatment [Internet]. PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute; 2016. [cited 2016 Jul 28]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26389388
   Google Scholar
• High WA, Robinson WA. Genetic mutations involved in melanoma: a summary of our current understanding. Adv Dermatol. 2007;23:61–79.
   PubMedGoogle Scholar
• Read J, Wadt KAW, Hayward NK. Melanoma genetics. J Med Genet. 2016;53(1):1–14.
   PubMed Web of Science ®Google Scholar
• Haass NK, Smalley KSM, Li L, et al. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res. 2005;18(3):150–159.
   PubMedGoogle Scholar
• Zhu N, Eves PC, Katerinaki E, et al. Melanoma cell attachment, invasion, and integrin expression is upregulated by tumor necrosis factor alpha and suppressed by alpha melanocyte stimulating hormone. J Invest Dermatol. 2002;119(5):1165–1171.
   PubMed Web of Science ®Google Scholar
• Ruoslahti E. Integrins. J Clin Invest. 1991;87(1):1–5.
   PubMed Web of Science ®Google Scholar
• Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69(1):11–25.
   PubMed Web of Science ®Google Scholar
• Kuphal S, Bauer R, Bosserhoff A-K. Integrin signaling in malignant melanoma. Cancer Metastasis Rev. 2005;24(2):195–222.
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ. Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med. 1999;222(2):124–138.
   PubMed Web of Science ®Google Scholar
• Koistinen P, Heino J. Integrins in cancer cell invasion. Madame Curie Bioscience Database [Internet]. Austin (TX): Landes Bioscience; 2013.
   Google Scholar
• Hynes RO, Vuori K, Wang H, et al. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110(6):673–687.
   PubMed Web of Science ®Google Scholar
• Aoudjit F, Vuori K. Integrin signaling in cancer cell survival and chemoresistance. Chemother Res Pract. 2012;2012:283181.
   PubMedGoogle Scholar
• Pinon P, Wehrle-Haller B. Integrins: versatile receptors controlling melanocyte adhesion, migration and proliferation. Pigment Cell Melanoma Res. 2011;24(2):282–294.
   PubMed Web of Science ®Google Scholar
• Hehlgans S, Haase M, Cordes N. Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta. 2007;1775:163–180.
   PubMed Web of Science ®Google Scholar
• Stupack DG, Cheresh DA. Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci. 2002;115(19):3729–3738.
   PubMed Web of Science ®Google Scholar
• Danen E. Integrin signaling as a cancer drug target. ISRN Cell Biol. 2013; 2013:1–14.
   Google Scholar
• Weis SM, Cheresh DA. alphaV integrins in angiogenesis and cancer. Cold Spring Harb Perspect Med. 2011;1(1):a006478.
   PubMed Web of Science ®Google Scholar
• van der Flier A, Sonnenberg A. Function and interactions of integrins. Cell Tissue Res. 2001;305(3):285–298.
   PubMed Web of Science ®Google Scholar
• Natali PG, Nicotra MR, Bartolazzi A, et al. Integrin expression in cutaneous malignant melanoma: association of the alpha 3/beta 1 heterodimer with tumor progression. Int J Cancer. 1993;54(1):68–72.
   PubMed Web of Science ®Google Scholar
• Yoshinaga IG, Vink J, Dekker SK, et al. Role of alpha 3 beta 1 and alpha 2 beta 1 integrins in melanoma cell migration. Melanoma Res. 1993;3(6):435–441.
   PubMed Web of Science ®Google Scholar
• Holzmann B, Gosslar U, Bittner M. alpha 4 integrins and tumor metastasis. Curr Top Microbiol Immunol. 1998;231:125–141.
   PubMed Web of Science ®Google Scholar
• Natali PG, Nicotra MR, Cavaliere R, et al. Tumor progression in human malignant melanoma is associated with changes in alpha 6/beta 1 laminin receptor. Int J Cancer. 1991;49(2):168–172.
   PubMed Web of Science ®Google Scholar
• Ziober BL, Chen YQ, Ramos DM, et al. Expression of the alpha7beta1 laminin receptor suppresses melanoma growth and metastatic potential. Cell Growth Differ. 1999;10(7):479–490.
   PubMedGoogle Scholar
• Kramer RH, Vu M, Cheng YF, et al. Integrin expression in malignant melanoma. Cancer Metast Rev. 1991;10(1):49–59.
   PubMed Web of Science ®Google Scholar
• Albelda SM, Mette SA, Elder DE, et al. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res. 1990;50(20):6757–6764.
   PubMed Web of Science ®Google Scholar
• Desgrosellier JS, Barnes LA, Shields DJ, et al. An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat Med. 2009;15(10):1163–1169.
   PubMed Web of Science ®Google Scholar
• Hieken TJ, Ronan SG, Farolan M, et al. Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma. Cancer. 1999;85(2):375–382.
   PubMed Web of Science ®Google Scholar
• Seguin L, Desgrosellier JS, Weis SM, et al. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol. 2015;25(4):234–240.
   PubMed Web of Science ®Google Scholar
• Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10(1):9–22.
   PubMed Web of Science ®Google Scholar
• Marshall JF, Rutherford DC, Happerfield L, et al. Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas. Br J Cancer. 1998;77(4):522–529.
   PubMed Web of Science ®Google Scholar
• Delamarre E, Taboubi S, Mathieu S, et al. Expression of integrin alpha6beta1 enhances tumorigenesis in glioma cells. Am. J. Pathol. 2009;175(2):844–855.
   PubMed Web of Science ®Google Scholar
• Stewart RL, O'Connor KL. Clinical significance of the integrin α6β4 in human malignancies. Lab Invest. 2015;95(9):976–986.
   PubMed Web of Science ®Google Scholar
• Okamoto M, Liu W, Luo Y, et al. Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem. 2010;285(9):6477–6488.
   PubMed Web of Science ®Google Scholar
• Kim H-Y, Lee H, Kim S-H, et al. Discovery of potential biomarkers in human melanoma cells with different metastatic potential by metabolic and lipidomic profiling. Sci Rep. 2017;7(1):8864
   PubMedGoogle Scholar
• Lydolph MC, Morgan-Fisher M, Høye AM, et al. α9β1 Integrin in melanoma cells can signal different adhesion states for migration and anchorage. Exp Cell Res. 2009;315(19):3312–3324.
   PubMed Web of Science ®Google Scholar
• Anz D, Mueller W, Golic M, et al. CD103 is a hallmark of tumor-infiltrating regulatory T cells. Int J Cancer. 2011;129(10):2417–2426.
   PubMed Web of Science ®Google Scholar
• Schlickum S, Sennefelder H, Friedrich M, et al. Integrin alpha E (CD103) beta 7 influences cellular shape and motility in a ligand-dependent fashion. Blood. 2008;112(3):619–625.
   PubMed Web of Science ®Google Scholar
• Kilshaw PJ. Alpha E beta 7. Mol Pathol. 1999;52(4):203–207.
   PubMedGoogle Scholar
• Siegers GM. Integral roles for integrins in γδ T cell function. Front Immunol. 2018;9:521.
   PubMed Web of Science ®Google Scholar
• Liu Y-X, Zhang F, Yao Q-M, et al. Expression of CD11a in lymphocyte subpopulation in immune thrombocytopenia. Int J Clin Exp Pathol. 2015;8(12):15642–15651.
   PubMed Web of Science ®Google Scholar
• Li F, Liu Y, Kan X, et al. Elevated expression of integrin αv and β5 subunit in laryngeal squamous-cell carcinoma associated with lymphatic metastasis and angiogenesis. Pathol Res Pract. 2013;209(2):105–109.
   PubMed Web of Science ®Google Scholar
• Bai SY, Xu N, Chen C, et al. Integrin αvβ5 as a biomarker for the assessment of non-small cell lung cancer metastasis and overall survival. Clin Respir J. 2015;9(4):457–467.
   PubMed Web of Science ®Google Scholar
• Bates RC, Bellovin DI, Brown C, et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest. 2005;115(2):339–347.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay A, Raghavan S. Defining the role of integrin alphavbeta6 in cancer. Curr Drug Targets. 2009;10(7):645–652.
   PubMed Web of Science ®Google Scholar
• Zambruno G, Marchisio P, Melchiori A, et al. Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes. J Cell Sci. 1993;105:179–190.
   PubMed Web of Science ®Google Scholar
• Dolcetti R, Giardini R, Doglioni C, et al. Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas. Am J Pathol. 1997;150(5):1595–1605.
   PubMed Web of Science ®Google Scholar
• Koistinen P, Ahonen M, Kähäri V-M, et al. αV integrin promotesin vitro andin vivo survival of cells in metastatic melanoma. Int J Cancer. 2004;112(1):61–70.
   PubMedGoogle Scholar
• Danen EH, Ten Berge PJ, Van Muijen GN, et al. Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression. Histopathology. 1994;24(3):249–256.
   PubMed Web of Science ®Google Scholar
• Mortarini R, Gismondi A, Santoni A, et al. Role of the alpha 5 beta 1 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectin. Cancer Res. 1992;52(16):4499–4506.
   PubMed Web of Science ®Google Scholar
• Nikkola J, Vihinen P, Vlaykova T, et al. Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma. Melanoma Res. 2004;14(1):29–37.
   PubMed Web of Science ®Google Scholar
• Benedetto S, Pulito R, Crich SG, et al. Quantification of the expression level of integrin receptor αvβ3 in cell lines and MR imaging with antibody-coated iron oxide particles. Magn Reson Med. 2006;56(4):711–716.
   PubMed Web of Science ®Google Scholar